Loading...
Derniers dépôts
Nombre de notices
1 614
Nombre de documents
1 443
Répartition par type de documents
Evolution
Dernières publications
-
Adriana Traore, Kelly Charniga, Sophie Grellet, Garance Terpant, Héléna da Cruz, et al.. Monitoring SARS-CoV-2 variants with complementary surveillance systems: risk evaluation of the Omicron JN.1 variant in France, August 2023 to January 2024. Eurosurveillance, 2025, 30 (1), pp.1192-1194. ⟨10.2807/1560-7917.ES.2025.30.1.2400293⟩. ⟨hal-04895964⟩
-
Sarah Soueges, Emmanuel Faure, Perrine Parize, Fanny Lanternier-Dessap, Hervé Lecuyer, et al.. Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant Gram-negative bacteria: CEFI-ID.. Journal of Infection, 2025, 90 (1), pp.106376. ⟨10.1016/j.jinf.2024.106376⟩. ⟨hal-04885304⟩
-
Alexia Rivera, Josée Dussault, Damien Oudin Doglioni, Sandra Chyderiotis, Jonathan Sicsic, et al.. Sociodemographic determinants of HPV vaccine awareness, uptake, and intention among parents of adolescents in France 2021-22. Human Vaccines & Immunotherapeutics, 2024, 20 (1), pp.2381300. ⟨10.1080/21645515.2024.2381300⟩. ⟨hal-04747813⟩
-
Dominique Ploin, Mathilde Alexandre, Bruno Ventelou, Didier Che, Bruno Coignard, et al.. Prioritisation of infectious diseases from a public health perspective: a multi-criteria decision analysis study, France, 2024. Eurosurveillance, 2024, 29 (50), pp.2400074. ⟨10.2807/1560-7917.ES.2024.29.50.2400074⟩. ⟨hal-04842113⟩
-
Damien Oudin Doglioni, Aurélie Gauchet, Amandine Gagneux-Brunon, Sébastien Bruel, Anne-Sophie Banaszuk, et al.. Shared human papillomavirus vaccine readiness within families: A psychometric analysis of parent–adolescent dyads in France.. Health Psychology, 2024, 43 (12), pp.893-903. ⟨10.1037/hea0001387⟩. ⟨hal-04692295⟩
-
Carla Faivre, Farras Daffa Imtiyaz, Julien Buyck, Sandrine Marchand, Melissa Marcotte, et al.. (E, E)-farnesol and myristic acid-loaded lipid nanoparticles overcome colistin resistance in Acinetobacter baumannii. International Journal of Pharmaceutics, 2024, 667 (A), pp.124907. ⟨10.1016/j.ijpharm.2024.124907⟩. ⟨hal-04766832⟩